Monitor Quote Charts Trades News Financials Toplists Alerts Portfolio Level 2 Forex Boards   25/11/2009 08:35:28 Site map   Help   Financials Sector Sheet Search by Sector FilterX For help & enquiries: 1-888-99-ADVFN (toll free)

E-Therapeutics Company Financial Information E-Therapeutics share price | E-Therapeutics company information | E-Therapeutics Share Charts | E-Therapeutics Share News  Company name:  E-Therapeutics  EPIC:  ETX  Trading Currency:  GBX  Market Sector:  AIM  ISIN:  GB00B2823H99  Market Segment:  AIM  Share Type:  DE  WWW Address:  http://www.etherapeutics.co.uk/  Description:  ORD 0.1P  Industry Sector:  PHARMACEUTICALS & BIOTECHNOLOGY  Price  Price Change [%]  Bid  Ask  Open  High  Low  Volume  42.00   -0.5 [-1.18]  40.00  44.00  42.50  42.50  42.00  5,620  Market Cap. [m]  Shares In Issue [m]  Beta  EPS  DPS  PE Ratio  Yield  52-Wks-Range  27.48  65.42  0.46  -  -  -  -  44.50 - 28.50 E-Therapeutics Key Figures (at previous day's close) Market Cap. 27.48 m Shares In Issue 65.42 m Prev. Close 42.50 PE Ratio -   Dividend Yield - % EPS - basic - p Dividend PS - p Dividend Cover -   Cash Flow PS - p Return On Equity (ROE) - % Operating Margin - % PEG Factor -   EPS Growth Rate - % Dividends PS Growth Rate - % Net Debt - m Gross Gearing - % Quick Assets - m Net Working Capital - m Intangibles / Fixed Assets - % Turnover PS - p Pre-Tax Profit PS - p Retained Profit PS - p Cash PS - p Net Cash PS - p Net Tangible Asset Value PS * - p Net Asset Value PS - p Spread 4.00 (9.09%)   * Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies. E-Therapeutics Balance Sheet Sorry No Data Available E-Therapeutics Share Price Sample Period † High Low 1 week 44.00 40.50 4 weeks 44.00 40.50 12 weeks 44.00 39.50 1 year 44.50 28.50 E-Therapeutics Share Price (5 years) E-Therapeutics Historic Returns Giorni da oggi † Open Change % Open Avg. Avg. Daily Vol [m] Total Vol [m] VWAP 1 week 42.50 -0.50 -1.18 42.50 0.00 - 42.50 4 weeks 43.00 -1.00 -2.33 42.70 0.00 - 42.63 12 weeks 41.00 1.00 2.44 42.06 0.01 - 41.83 26 weeks 34.50 7.50 21.74 38.02 0.02 - 35.70 1 year 35.00 7.00 20.00 36.72 0.01 - 35.62 3 years 67.50 -25.50 -37.78 39.25 0.01 - 38.02 5 years 67.50 -25.50 -37.78 39.25 0.01 - 38.02 † periods calculated are whole weeks rather than calendar months E-Therapeutics Key Management Ratios E-Therapeutics Investment Ratios (Market value analysis) at previous day's close PQ Ratio -   PE Ratio -   Tobin's Q Ratio -   Tobin's Q Ratio (excl. intangibles) -   Dividend Yield - % Market-to-Book Ratio -   Price-to-Pre-Tax Profit PS -   Price-to-Retained Profit PS -   Price-to-Cash Flow PS -   Price-to-Sales PS -   Price-to-Net Tangible Asset Value PS -   Price-to-Cash PS -   Net Working Capital PS -   Price Pct to Working Capital PS - % Earnings Yield - % Average PE -   Years in average -   PE to PE average - % E-Therapeutics Financial Ratios (Leverage Ratios) Debt Ratio - % Debt-to-Equity Ratio -   Debt-to-Equity Ratio (excl. Intgbl) -   Debt-to-Equity Market Value -   Net Gearing - % Net Gearing (excl. Intangibles) - % Gross Gearing - % Gross Gearing (excl. Intangibles) - % Gearing Under 1 Year - % Gearing Under 1 Year (excl. Intgbl) - % Assets/Equity -   Cash/Equity -   (Liquidity Ratios) Net Working Capital to Total Assets - % Current Ratio -   Quick Ratio (Acid Test) -   Liquidity Ratio -   Cash & Equiv/Current Assets - % (Solvency Ratios) Enterprise Value 27.48 m CFO/Sales -   CFO/Attributable Profit -   CFO/Assets -   CFO/Debt -   Total Debt/Equity Market Value -   Total Debt/Sales -   Total Debt/Pre-Tax Profit -   Total Debt - m Total Debt/Net Current Assets - % (Dodds - Graham Ratios) 3 yr Compound Earnings Growth - % 5 yr Compound Earnings Growth - % 10 yr Compound Earnings Growth - % Earn drops > 5% in 10yrs -   Beta (60-Mnth) Beta (36-Mnth) 0.4608 0.4608 Alpha (60-Mnth) Alpha (36-Mnth) -0.0004 -0.0004 E-Therapeutics Operating Ratios (Profitability Ratios) Return On Capital Employed (ROCE) - % Return On Assets (ROA) - % Net Profit Margin - % Assets Turnover -   Return On Equity (ROE) - % Return On Investment (ROI) - % Dividend Payout Ratio - % Plowback Ratio 100.00 % Growth from Plowback Ratio - % Net Income Of Revenues - % (Asset Utilisation Multiples) Shareholders Equity Turnover -   Fixed Assets Turnover -   Current Assets Turnover -   Net Working Capital Turnover -   Inventory Turnover -   (Other Operating Ratios) Total Assets-to-Sales -   Debtors-to-Sales - % Debt Collection Period - Days E-Therapeutics Dividends %1$s Dividends E-Therapeutics Fundamentals Profit and Loss Account E-Therapeutics Balance Sheet %1$s Balance Sheet E-Therapeutics Cash Flow Statement %1$s Cash Flow Statement E-Therapeutics Brokers Name Activity Type Mnemonic Code Shore Capital Stockbrokers Ld Market Maker(MMF) Broker/Dealer SCAP SHOCGB21 Winterflood Secs Ld Market Maker(MMF) Broker/Dealer WINS WNTSGB2LBIC

LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes. All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs

ADDITIONAL SERVICES AVAILABLE FROM ADVFN ADVFN Forex Channel Exchange Rates, FX Prices Charts, Forex Brokers & Currency Conversion

40 site:2us lse etx091125 08:35 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )